A 45-year-old Japanese man with Sjogren's syndrome developed recurrent skin ulcers, palpable purpura, and dyspnea. Serum mixed-type cryoglobulin level was elevated. A biopsy of his skin lesion showedthe characteristic leukocytoclastic vasculitis of mixed-type cryoglobulinemia. Dyspnea, skin ulcers, and purpura resolved along with a reduction in the serum cryoglobulin level after prednisolone administration. This patient demonstrated cryoglobulinemia-associated vasculitis, as well as possible cryoglobulinemia-associated pulmonary symptoms. (Internal Medicine 36: 62-67, 1997) 
Introduction
Cryoglobulins, defined as immunoglobulins which reversibly precipitate on exposure to cold temperatures, were first described by Wintrobe and Buell in 1933 (1) . Cryoglobulinemia is associated with various overlying diseases and involves a variety of symptomssuch as purpura, arthralgias, neuropathies, and hepatic and renal involvement. However, pulmonary symptoms as a result of cryoglobulinemia have not been clearly recognized. Here, we discuss a patient with leukocytoclastic vasculitis of the skin and pulmonary symptoms, which improved with corticosteroid treatment and maybe associated with mixed-type cryoglobulinemia.
Case Report
A 45-year-old Japanese manvisited the Department of Dermatology, Keio University Hospital in March 1993, with complaints of pigmentation and pain in his lower extremities. In June, he developed pulmonary embolism and was treated at another hospital. In August, the patient was admitted to the Department of Dermatology, Keio University Hospital because of multiple skin ulcers on his feet, elbows and scrotum and palpable purpura involving both legs. The skin ulcers resolved simply with application of a topical corticosteroid. Although he was discharged on December 14, he developed dyspnea on December 26, and was readmitted to the Department of Internal Medicine, Keio University Hospital on December 27, because of worsening dyspnea, leg purpura, and skin ulcers. The patient had a history of malignant lymphoma in 1985, but had been in complete remission for morethan 8 years after chemotherapy. On admission, his temperature was 36.6°C; pulse, 80; respiration, 20; and blood pressure, 122/72 mmHg.
Physical examination was remarkable for skin ulcers involving his feet, elbow, and scrotum, as well as pigmentation and palpable purpura affecting both lower extremities (Fig. 1) . The Table 2 . Anelectrocardiogram demonstrated a normal sinus rhythm and showed no evidence of right heart strain. A radiograph of the chest showed cardiomegaly without marked enlargement of the hilar regions or pulmonary infiltration ( Measurement was performed on admission while the patient was breathing 4 liters per minute of oxygen via nasal canula. **Measurement was performed while the patient was breathing room air. reatinine CRPPulmonary embolism (mg/dl) (mg/dl)^H^Dyspea^Hf Figure 7 . The clinical course of the patient.
initiated, however the dyspnea and skin ulcers worsened. On the presumption that systemic vasculitis associated with mixed-type cryoglobulinemia was causing his clinical manifestations, 60 mg/day of prednisolone was started on January 10, 1994. As shown in Fig. 7 and Table 2 , dyspnea, skin ulcers, arterial blood gas values, CRP, creatinine, bile duct enzyme and cryoglobulin levels markedly improved within one week after the start of prednisolone administration. The hemoglobin level gradually increased and returned to the normal level on February 28. A follow-up pulmonary scintigraphy performed on January 19 demonstrated no substantial changes. However, Raynaud ' s phenomenonbecame apparent after the prednisolone was tapered to less than 20 mg/day. Whenprednisolone was further tapered to 1 3 mg, the cryoglobulin level increased again, followed by an exacerbation of his skin ulcers. Then 10 jag of prostaglandin El (alprostadil) was given intravenously every day, which had only a limited effect on skin ulcers. Oral administration of 100 mg of azathioprine was not effective either. Once prednisolone was increased back to 20 mg/day, the skin ulcers and Raynaud's phenomenonresolved along with a reduction of the serum cryoglobulin level.
Discussion
Cryoglobulin has been classified into three types (2): Type I consists of a single monoclonalimmunoglobulincomponent;
Type II has mixed monoclonal and polyclonal immunoglobulin components; and Type III has polyclonal components. The present case showed striking levels of Type II cryoglobulinemia and a biopsy-proven vasculitis which was thought to have caused the skin ulcers and symptoms resembling pulmonary embolism.
Type II cryoglobulins, as detected in this case, consist of two components of immunoglobulin; mixed monoclonal (IgMkappa) and polyclonal (IgG) components. Tzioufas et al have reported that Sjogren's syndrome coexisted in 37%patients of type II cryoglobulinemia (3). They stressed high titers of serum anti-SS-A/Ro antibodies and markedly decreased levels of serum C4, both of which were demonstrated in the present case.
Although a precise etiologic role is still unknown,some form of antigenic stimulation in Sjogren's syndrome may play a primary role in the production of cryoglobulin (4) . Our analysis demonstrated the presence of anti-SSA/Ro antibodies from IgG component ofcryoglobulin. This result suggests that anti-SSA/ Ro antibodies may be involved in the formation of cryoglobulin.
Eighty percent of patients with cryoglobulinemia reveal clinical manifestations (5). Cutaneous involvement is most common and sometimes the first symptom in type II cryglobulinemia. Cohen et al (5) have reported distribution of type II cryoglobulinemia-related skin lesions as: 100% in the lower extremities, 41% in the upper extremities, 22% in the trunk, 11% in the head and neck, and 5% in the oral and nasal mucosa (5) . The present patient showed skin manifestations in all of these regions except the head and neck. Although the existence of a correlation betweencold temperatures and clinical manifestations is controversial (6), in our patient, the skin lesions including the skin ulcers, Raynaud's phenomenonand palpable purpura tended to be exacerbated during the winter. Anemia occurs in 70%of cases (6), but evaluation for specific etiologies are generally unrevealing. Rare cases of type II cryoglobulinemia associated with hemolytic anemia have been reported (6) . In the present case, hematologic data suggested the possibility that the anemia was accompanied by chronic inflammation.
Hepatic involvement of cryoglobulinemia has been reported in 8%of cases and an elevated level of serum alkaline phosphatase is known to be the most frequent abnormality (6) . Although there have been manyreports on the association between cryoglobulinemia and hepatitis virus infection (7-9), the present patient had no history of liver diseases or serologic evidence of viral hepatitis. Rather, cryoglobulinemia-associated liver dysfunction appears to be most reasonable since the elevated liver enzyme concentrations returned to normal along with the reduction of the serum cryoglobulin level.
Renal involvement is sometimes fatal in patients with cryoglobulinemia. Therefore, we attempted a renal biopsy of the patient, but no renal specimen was obtained. In this patient, renal dysfunction was successfully improved along with the reduction of serum cryoglobulin concentration after the prednisolone administration. As reported in the literature (4, 6), rapidly progressive renal failure might have lead to a poorer prognosis of the patient.
Mautner et al have reported a case of cryoglobulinemiarelated vasculitis in a patient with a malignancy (10). The present patient had a history of malignant lymphoma, however, he had been in complete remission for more than 8 years and no apparent relapse of the lymphoma was observed. Although pulmonary embolism cannot be ruled out in this case, all the diagnostic information was not typical of pulmonary embolism. Roithinger et al have reported a patient who developed chronic hepatitis C virus infection, glomerulonephritis , and cryoglobulinemia complicated by immunologically mediated pulmonary vasculitis, and ultimate death from respiratory failure (1 1). In this regard, it is important to emphasize that in the present patient, pulmonary symptomsappeared to correlate with the serum cryoglobulin level and improved immediately after corticosteroid administration. The clinical data of this patient suggests that the respiratory symptomsand hypoxemia might have been caused by a small-vessel vasculitis or a small vascular occlusion associated with the cryoglobulin.
